Person profile
Public information reviewedMichael Henderson, M.D.
Board role
Director · Spyre Therapeutics, Inc. (NASDAQ: SYRE)
Spyre Therapeutics, Inc. (NASDAQ: SYRE)
Director · Current mandate
- Public sources
- 2 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- Sep 13, 2026
Alpha Registry